Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemente García-Rizo

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2026
Corrigendum to "Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls" [European Neuropsychopharmacology 81 (2024) 28-37]Alex G Segura, Elena de la Serna, Gisela Sugranyes, et al.
Revista De Psiquiatria Y Salud Mental|March 2, 2016
Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemiaÁngel L Montejo, Celso Arango, Miguel Bernardo, et al.
Schizophrenia Research|March 1, 2022
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophreniaMiquel Bioque, Gisela Mezquida, Sílvia Amoretti, et al.
Spanish Journal of Psychiatry and Mental Health|November 16, 2025
From premorbid adjustment dimensions to clinical outcomes: Exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypesAnaid Pérez-Ramos, Àlex Gonzalez-Segura, Laura Julià, et al.
Spanish Journal of Psychiatry and Mental Health|September 16, 2023
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patientsGisela Mezquida, Silvia Amoretti, Miquel Bioque, et al.
Frontiers in Neuroendocrinology|February 26, 2017
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychoticsÁngel L Montejo, Celso Arango, Miquel Bernardo, et al.
Bjpsych Open|August 1, 2024
Identifying digital biomarkers of illness activity and treatment response in bipolar disorder with a novel wearable device (TIMEBASE): protocol for a pragmatic observational clinical studyGerard Anmella, Filippo Corponi, Bryan M Li, et al.
JMIR Mhealth and Uhealth|March 20, 2023
Exploring Digital Biomarkers of Illness Activity in Mood Episodes: Hypotheses Generating and Model Development StudyGerard Anmella, Filippo Corponi, Bryan M Li, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2026
Corrigendum to "Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls" [European Neuropsychopharmacology 81 (2024) 28-37]Alex G Segura, Elena de la Serna, Gisela Sugranyes, et al.
Revista De Psiquiatria Y Salud Mental|March 2, 2016
Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemiaÁngel L Montejo, Celso Arango, Miguel Bernardo, et al.
Schizophrenia Research|March 1, 2022
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophreniaMiquel Bioque, Gisela Mezquida, Sílvia Amoretti, et al.
Spanish Journal of Psychiatry and Mental Health|November 16, 2025
From premorbid adjustment dimensions to clinical outcomes: Exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypesAnaid Pérez-Ramos, Àlex Gonzalez-Segura, Laura Julià, et al.
Spanish Journal of Psychiatry and Mental Health|September 16, 2023
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patientsGisela Mezquida, Silvia Amoretti, Miquel Bioque, et al.
Frontiers in Neuroendocrinology|February 26, 2017
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychoticsÁngel L Montejo, Celso Arango, Miquel Bernardo, et al.
Bjpsych Open|August 1, 2024
Identifying digital biomarkers of illness activity and treatment response in bipolar disorder with a novel wearable device (TIMEBASE): protocol for a pragmatic observational clinical studyGerard Anmella, Filippo Corponi, Bryan M Li, et al.
JMIR Mhealth and Uhealth|March 20, 2023
Exploring Digital Biomarkers of Illness Activity in Mood Episodes: Hypotheses Generating and Model Development StudyGerard Anmella, Filippo Corponi, Bryan M Li, et al.
Pageof 6